Epi proColon®

The first and only FDA-approved blood test colorectal cancer screening for people who are unwilling or unable to be screened by recommended methods.

Rx Only

Contact Us

In the US, 1 in 3, or 23 million eligible people are not screened for colon cancer.

As a consequence, 60% of colon cancer cases are diagnosed at a late stage, when the cancer has already spread and treatment becomes more challenging.

For those people who have a history of not completing screening by guideline recommended methods, there is now a blood test. Epi proColon is the first and only FDA approved blood test for colon cancer screening. Benefits of Epi proColon include:

No pretest preparation

No stool handling

No dietary or medication restrictions

Available through national laboratories